Polio

Recent News

Apr 28, 2017
polio vaccine supplies

WHO vaccine advisors weigh in on polio, cholera, Ebola, diphtheria

Experts made more recommendations about fractional IPV dosing and also discussed issued related to cholera, Ebola, and diphtheria.

Apr 26, 2017

News Scan for Apr 26, 2017

Raw milk burden
Saudi MERS case
H9N2 case in China
New polio vaccine
Chikungunya in Pakistan
Mar 23, 2017

News Scan for Mar 23, 2017

Antibiotic resistance in the community
Zika testing in pregnancy
Africa polio vaccination
Meningitis outbreak conviction
Mar 15, 2017

News Scan for Mar 15, 2017

Polio case in Pakistan
Antibiotic-resistant eye infections
Feb 23, 2017

News Scan for Feb 23, 2017

More H5N8 outbreaks
Zika testicular shrinkage
Polio still global emergency
Norovirus tracking
Feb 21, 2017

News Scan for Feb 21, 2017

H7N9 cases in China
Poultry worker avian flu exposure
Yemen polio campaign
Multi-disease mosquito vaccine
Feb 01, 2017

News Scan for Feb 01, 2017

More H5N8
Plague cases, treatment
MERS-CoV in camels
Afghanistan polio vaccine drive
Jan 12, 2017

News Scan for Jan 12, 2017

More H7N9 in China
Fractional polio vaccine
Hand washing at fairs
Jan 04, 2017

News Scan for Jan 04, 2017

Pakistani polio campaign
Health workers concerned about MERS
Dec 28, 2016

News Scan for Dec 28, 2016

More Saudi MERS cases
Abx prescription feedback
Pakistan polio update
Chikungunya update

Resources & Literature

Recent Literature

Bahl S, Hampton LM, Bhatnagar P, et al. Detection of Sabin-like type 2 poliovirus from sewage after global cessation of trivalent oral poliovirus vaccine — Hyderabad and Ahmedabad, India, August-September 2016. (Notes from the field) MMWR 2017 Jan 6;65(52):1493-4

Benn CS, Jacobsen LH, Fisker AB, et al. Campaigns with oral polio vaccine may lower mortality and create unexpected results. Vaccine 2017 (published online Jan 27)

Berchenko Y, Manor Y, Freedman LS, et al. Estimation of polio infection prevalence from environmental surveillance data. Sci Transl Med 2017 Mar 29;9(383):eaaf6786

Collett MS, Hincks JR, Benschop K, et al. Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model. J Infect Dis 2016 (published online Dec 8)

Habib MA, Soofi S, Mach O, et al. Effect of booster doses of poliovirus vaccine in previously vaccinated children, clinical trial results 2013. Vaccine 2016 (published online Jun 16)

Hampton LM, Farrell M, Ramirez-Gonzalez A, et al. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine worldwide, 2016. MMWR 2016 Sep 9;65(35):934-8

Hsu CH, Mahamud A, Safdar RM, et al. Progress toward poliomyelitis eradication — Pakistan, January 2015-September 2016. MMWR 2016 Nov 25;65(46):1295-9

John J, Giri S, Karthikeyan AS, et al. The duration of intestinal immunity after an inactivated poliovirus vaccine booster dose in children immunized with oral vaccine: a randomised controlled trial. J Infect Dis 2016 (published online Dec 21)

Liao G, Li R, Li C, et al. Phase III trial of a Sabin strain-based inactivated poliovirus vaccine. J Infect Dis 2016 (published online Sep 22)

Maes EF, Diop OM, Jorba J, et al. Surveillance systems to track progress toward polio eradication — worldwide, 2014-2016. MMWR Apr 7;66(13):359-65

Marin M, Patel M, Oberste S, et al. Guidance for assessment of poliovirus vaccination status and vaccination of children who have received poliovirus vaccine outside the United States. MMWR 2017 Jan 13;66(01):23-5

Mbaeyi C, Ryan MJ, Smith P, et al. Response to a large polio outbreak in a setting of conflict Middle East, 2013-2015. MMWR 2017 Mar 3;66(8):227-31

Mbaeyi C, Shukla H, Smith P, et al. Progress toward poliomyelitis eradication — Afghanistan, January 2015-August 2016. MMWR 2016 Nov 4;65(43):1195-9

Moeti M. Winning the battle against the scourge of poliomyelitis in the African region. Vaccine 2016 (published online Aug 27)

Musa A, Abba B, Ningi AMI, et al. Enhancing transit polio vaccination in collaboration with targeted stakeholders in Kaduna State, Nigeria: lessons learnt: 2014-2015. Vaccine 2016 (published online Jun 27)

Nnadi C, Damisa E, Esapa L, et al. Continued endemic wild poliovirus transmission in security-compromised areas — Nigeria, 2016. MMWR 2017 Feb 24;66(7):190-3

Pons-Salort M, Molodecky NA, O'Reilly KM, et al. Population immunity against serotype-2 poliomyelitis leading up to the global withdrawal of the oral poliovirus vaccine: spatio-temporal modelling of surveillance data. PLoS Med 2016 Oct 4;13(10):e1002140

Rivera L, Pedersen RS, Pena L, et al. Immunogenicity and safety of three aluminum hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial. Lancet Infect Dis 2017 (published online Apr 25)

Shirreff G, Wadood MZ, Vaz RG, et al. Estimated effect of inactivated poliovirus vaccine campaigns, Nigeria and Pakistan, January 2014-April 2016. Emerg Infect Dis 2016 (published online Nov 18)

Weil M, Shulman LM, Heiman S, et al. Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016. Euro Surveill 2016 Nov 24;21(47):pii=30408

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MGilead Become an underwriter»